News for Healthier Living

Mayo Clinic Study Shows Blood Biomarker May Help Estimate Cognitive Impairment Risk

A blood biomarker for Alzheimer's disease may help estimate a cognitively healthy person's risk of developing mild cognitive impairment or dementia over the next five or 10 years, according to a new Mayo Clinic study in JAMA Neurology.

November 16, 2026


November 16 2026

November 15 2026

November 13 2026

November 12 2026

November 11 2026

November 10 2026

November 9 2026

November 8 2026

November 7 2026

November 6 2026

November 5 2026

November 4 2026

November 3 2026